Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-24 @ 9:59 PM
NCT ID:
NCT00315432
Eligibility Criteria:
Inclusion Criteria:
* HIV- infected patients confirmed by HIV-RNA level
* HCV- infected patients confirmed by PCR(polymerase chain reaction) or branched DNA (b-DNA)
* Scheduled to commence combination IFN/RBV therapy on Day 1
* Normal serum creatinine
* On stable antiretroviral regimen (for HIV) for at least 4 weeks
* Life expectancy \> 6 months
Exclusion Criteria:
* Patients with history of any primary hematologic disease
* Anemia attributable to factors such as iron or folate deficiency, pre-treatment
* hemolysis or gastrointestinal bleeding
* Has suspected or confirmed significant hepatic disease from an etiology other than
* HCV (e.g. alcohol, HBV DNA, autoimmune disease etc)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00315432
Study Brief:
Protocol Section:
NCT00315432